Literature DB >> 1321053

Ultrastructural, immunochemical, and cytochemical study of myeloperoxidase in myeloid leukemia HL-60 cells following treatment with succinylacetone, an inhibitor of heme biosynthesis.

V L Castañeda1, R T Parmley, I B Pinnix, S G Raju, G S Guzman, J M Kinkade.   

Abstract

Myeloperoxidase (MPO) is a heme-containing glycoprotein found in the primary granules (or azurophilic granules) of human polymorphonuclear leukocytes. In the present study, cultured myeloid leukemia HL-60 cells were exposed for 0-72 h to 250 microM 4,6-dioxoheptanoic acid (succinylacetone, SA), a specific inhibitor of heme biosynthesis, and the effects were evaluated using ultrastructural, immunochemical, and cytochemical methods. En bloc peroxidase staining of glutaraldehyde-fixed cells was accomplished with a 30-min exposure to 3,3'-diaminobenzidine (DAB) tetrahydrochloride. Ultrastructural examination revealed that peroxidase reactivity in the endoplasmic reticulum (ER) was relatively unchanged for 8 h and decreased between 12 and 24 h; however, ER lacked DAB-reactive peroxidase at 48-72 h. Peroxidase reactivity in the ER reappeared within 4 h after removal of SA. Seventy-two hours after exposure to SA the number of condensed cytoplasmic granules stained with DAB was significantly decreased, and many of the granules had a "target" appearance with a central DAB-reactive dense core. Staining of mitochondria was observed with overnight exposure to DAB and persisted in HL-60 cells treated 72 h with SA. Mitochondrial and nuclear morphology appeared unaltered. Immunostaining of MPO in thin sections of paraformaldehyde/glutaraldehyde-fixed unosmicated HL-60 cells, embedded in Lowicryl K4M, was accomplished with sequential exposure to an affinity-purified monospecific rabbit antibody to HL-60-MPO and protein A conjugated to 5- or 10-nm colloidal gold. Compared to untreated control HL-60 cells, cells exposed to SA for 48 h exhibited comparable to increased immunoreactive MPO in the ER, despite the absence of heme-dependent peroxidase reactivity. The data indicate that SA inhibits formation of enzymatically active MPO and that in the presence of SA, the ER contains a form(s) of MPO that lacks enzymatic reactivity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321053

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  5 in total

Review 1.  Biosynthesis of human myeloperoxidase.

Authors:  William M Nauseef
Journal:  Arch Biochem Biophys       Date:  2018-02-03       Impact factor: 4.013

2.  Functional consequence of positive selection revealed through rational mutagenesis of human myeloperoxidase.

Authors:  Noeleen B Loughran; Sara Hinde; Sally McCormick-Hill; Kevin G Leidal; Sarah Bloomberg; Sinéad T Loughran; Brendan O'Connor; Ciarán O'Fágáin; William M Nauseef; Mary J O'Connell
Journal:  Mol Biol Evol       Date:  2012-02-21       Impact factor: 16.240

3.  Proconvertase proteolytic processing of an enzymatically active myeloperoxidase precursor.

Authors:  Sally McCormick; Angela Nelson; William M Nauseef
Journal:  Arch Biochem Biophys       Date:  2012-08-10       Impact factor: 4.013

4.  A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/proteasome degradation.

Authors:  F R DeLeo; M Goedken; S J McCormick; W M Nauseef
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

5.  Structure of human promyeloperoxidase (proMPO) and the role of the propeptide in processing and maturation.

Authors:  Irina Grishkovskaya; Martina Paumann-Page; Rupert Tscheliessnig; Johanna Stampler; Stefan Hofbauer; Monika Soudi; Benjamin Sevcnikar; Chris Oostenbrink; Paul G Furtmüller; Kristina Djinović-Carugo; William M Nauseef; Christian Obinger
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.